JP2007520206A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520206A5
JP2007520206A5 JP2006522631A JP2006522631A JP2007520206A5 JP 2007520206 A5 JP2007520206 A5 JP 2007520206A5 JP 2006522631 A JP2006522631 A JP 2006522631A JP 2006522631 A JP2006522631 A JP 2006522631A JP 2007520206 A5 JP2007520206 A5 JP 2007520206A5
Authority
JP
Japan
Prior art keywords
antibacterial peptides
antibacterial
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522631A
Other languages
English (en)
Japanese (ja)
Other versions
JP4734245B2 (ja
JP2007520206A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024627 external-priority patent/WO2005012492A2/en
Publication of JP2007520206A publication Critical patent/JP2007520206A/ja
Publication of JP2007520206A5 publication Critical patent/JP2007520206A5/ja
Application granted granted Critical
Publication of JP4734245B2 publication Critical patent/JP4734245B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006522631A 2003-08-01 2004-07-30 外因性ポリペプチドを発現するヒト皮膚等価物 Expired - Lifetime JP4734245B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49186903P 2003-08-01 2003-08-01
US60/491,869 2003-08-01
US49366403P 2003-08-08 2003-08-08
US60/493,664 2003-08-08
PCT/US2004/024627 WO2005012492A2 (en) 2003-08-01 2004-07-30 Human skin equivalents expressing exogenous polypeptides

Publications (3)

Publication Number Publication Date
JP2007520206A JP2007520206A (ja) 2007-07-26
JP2007520206A5 true JP2007520206A5 (enExample) 2010-12-16
JP4734245B2 JP4734245B2 (ja) 2011-07-27

Family

ID=34118888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522631A Expired - Lifetime JP4734245B2 (ja) 2003-08-01 2004-07-30 外因性ポリペプチドを発現するヒト皮膚等価物

Country Status (9)

Country Link
US (8) US7674291B2 (enExample)
EP (4) EP3473102A1 (enExample)
JP (1) JP4734245B2 (enExample)
AU (2) AU2004262002B2 (enExample)
CA (1) CA2534349C (enExample)
IL (1) IL173466A (enExample)
NZ (1) NZ545404A (enExample)
PT (1) PT3100611T (enExample)
WO (1) WO2005012492A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974697B2 (en) 2001-03-02 2005-12-13 Stratech Corporation Skin substitutes with improved barrier function
CA2483547C (en) * 2002-04-30 2012-03-20 Stratatech Corporation Keratinocytes expressing exogenous angiogenic growth factors
CA2534349C (en) 2003-08-01 2012-04-10 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
CA2600177C (en) * 2005-03-01 2011-06-14 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
EP2277899B1 (en) * 2006-04-27 2015-07-08 Singapore Health Services Pte Ltd Antimicrobial peptides
EP3375479B1 (en) 2007-05-18 2023-03-22 Boston Scientific Scimed, Inc. Medical drive systems
SI2514436T1 (en) * 2007-11-07 2018-04-30 Genentech, Inc. IL-22 for use in the treatment of microbial diseases
PT2215212T (pt) 2007-11-14 2017-12-01 Stratatech Corp Armazenamento a frio de equivalentes de pele cultivados de forma organotípica para aplicações clínicas
US9115180B2 (en) 2008-01-07 2015-08-25 Rapid Pathogen Screening, Inc. Use of peptides for promoting wound healing
ES2671143T3 (es) * 2008-01-07 2018-06-05 Rapid Pathogen Screening, Inc. Uso de péptidos para estimular la cicatrización de heridas
US8815177B2 (en) 2008-01-24 2014-08-26 Sandia Corporation Methods and devices for immobilization of single particles in a virtual channel in a hydrodynamic trap
EP2352472B1 (en) * 2008-11-04 2017-01-04 Stratatech Corporation Dried and irradiated skin equivalents for ready use
US20100330046A1 (en) * 2009-05-21 2010-12-30 Stratatech Corporation Human skin substitutes expressing il-12
DE102010004541A1 (de) * 2010-01-14 2011-07-21 Christian-Albrechts-Universität zu Kiel, 24118 Chimäre humane beta-Defensine
KR101329774B1 (ko) 2010-06-16 2013-11-15 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
US20130310326A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
PT2967836T (pt) * 2013-03-13 2019-01-21 Stratatech Corp Criopreservação de substitutos de pele humana viáveis
HK1218424A1 (zh) 2013-03-15 2017-02-17 F. Hoffmann-La Roche Ag Il-22多肽和il-22 fc融合蛋白及其使用方法
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CN111973805B (zh) * 2019-08-16 2022-03-01 苏州吉美瑞生医学科技有限公司 抗菌肽hCAP18/LL-37在抗感染生物工程肺中的应用
CN112220739B (zh) * 2020-10-15 2023-09-01 国润生物科技（深圳）有限公司 一种hpv病毒灭活敷料及其制备方法
KR102497294B1 (ko) * 2022-12-23 2023-02-14 주식회사 코씨드바이오팜 신규 펩타이드를 유효성분으로 포함하는 피부 질환 예방 및 개선용 피부 외용제 조성물

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
US4528265A (en) 1982-05-11 1985-07-09 Becker Robert O Processes and products involving cell modification
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5583024A (en) 1985-12-02 1996-12-10 The Regents Of The University Of California Recombinant expression of Coleoptera luciferase
US5128257A (en) * 1987-08-31 1992-07-07 Baer Bradford W Electroporation apparatus and process
IL95429A (en) 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
RU2135191C1 (ru) 1990-04-24 1999-08-27 Ортек Интернэшнл, Инк. Композиционный эквивалент живой кожи, способ его получения, тест-набор
IT1248934B (it) 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
AT401526B (de) 1993-02-10 1996-09-25 Scheirer Winfried Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6693077B1 (en) * 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US5693332C1 (en) 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5976796A (en) 1996-10-04 1999-11-02 Loma Linda University Construction and expression of renilla luciferase and green fluorescent protein fusion genes
US20020037566A1 (en) * 1997-04-16 2002-03-28 Rees Riley S. Cell-coated supports
US5968546A (en) 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells
US6074859A (en) 1997-07-08 2000-06-13 Kikkoman Corporation Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
US5994115A (en) 1997-07-22 1999-11-30 The Penn State Research Foundation Artificial system for the production of infectious human papillomavirus
US5989837A (en) 1998-07-13 1999-11-23 Wisconsin Alumni Research Foundation Immortalized human keratinocyte cell line
US6964869B2 (en) 1998-07-13 2005-11-15 Wisconsin Alumni Research Foundation Method and composition for skin grafts
AU5344399A (en) 1998-08-07 2000-02-28 General Mills Inc. Container for storing fine particles
MXPA02000152A (es) * 1999-07-02 2002-07-30 Human Genome Sciences Inc Factor 2 de crecimiento de queratinocitos.
PT1404809E (pt) 2001-03-02 2014-03-20 Stratatech Corp Substitutos de pele melhorados e suas utilizações
US6974697B2 (en) 2001-03-02 2005-12-13 Stratech Corporation Skin substitutes with improved barrier function
DE10151296A1 (de) * 2001-10-17 2003-04-30 Boehringer Ingelheim Pharma Keratinozyten verwendbar als biologisch aktive Substanz bei der Behandlung von Wunden
SE0300207D0 (sv) * 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
CA2534349C (en) 2003-08-01 2012-04-10 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
US8112550B2 (en) 2006-09-19 2012-02-07 Tacoda Llc System and method for preserving consumer choice
US8348604B2 (en) 2008-03-17 2013-01-08 Rolls-Royce Corporation Airfoil assembly and method of forming same
US8764102B2 (en) 2008-11-21 2014-07-01 Calsonic Kansei Corporation Structure of high-strength vehicle body member
US8764107B2 (en) 2010-01-29 2014-07-01 Kusch + Co. Gmbh & Co. Kg Seating furniture
CN101851716B (zh) 2010-06-14 2014-07-09 清华大学 镁基复合材料及其制备方法，以及其在发声装置中的应用
CN102469021B (zh) 2010-11-18 2014-08-13 杭州华三通信技术有限公司 一种智能弹性框架系统中转发业务流量的方法和成员设备

Similar Documents

Publication Publication Date Title
JP2006512924A5 (enExample)
JP2007520206A5 (enExample)
JP2008514563A5 (enExample)
JP2007515381A5 (enExample)
JP2006514019A5 (enExample)
JP2004244619A5 (enExample)
JP2004537984A5 (enExample)
JP2005194118A5 (enExample)
JP2005261231A5 (enExample)
JP2004168997A5 (enExample)
JP2006503960A5 (enExample)
JP2005533836A5 (enExample)
JP2003305787A5 (enExample)
JP2007505861A5 (enExample)
JP2005120465A5 (enExample)
JP2006510481A5 (enExample)
JP2005095148A5 (enExample)
JP2007500762A5 (enExample)
JP2005290409A5 (enExample)
JP2005523387A5 (enExample)
JP2004262980A5 (enExample)
JP2006101735A5 (enExample)
JP2005264095A5 (enExample)
JP2006096807A5 (enExample)
JP2005002267A5 (enExample)